Skip to content

Effects of dexamethasone combined with auricular plaster therapy and transcutaneous electrical acupoint stimulation on rebound pain after peripheral nerve block

Effects of dexamethasone combined with auricular plaster therapy and transcutaneous electrical acupoint stimulation on rebound pain after peripheral nerve block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000834
Enrollment
Unknown
Registered
2024-12-17
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the rebound pain after peripheral nerve block

Interventions

Test group:Dexamethasone combined with comprehensive acupoint stimulation
Control group:Dexamethasone combined with the acupoint stimulation at sham acupoints or without embedding seeds and pressure

Sponsors

Xiangyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: The orthopaedic patient with unilateral closed fracture of upper limb (humerus and below) in Xiangyang Central Hospital aged 18-80 years old ASA I-III grade who intend to undergo their first open reduction and internal fixation of unilateral fracture of upper limb (humerus and below) under brachial plexus block (intermuscular sulcus+axillary route).

Exclusion criteria

Exclusion criteria: 1: Patients with other site surgery 2: Emergency patients 3: Peripheral neuropathy preoperative operative upper limb with nerve injury 4: Previous axillary surgery on the operative side 5: Multiple operations on the upper limb of the surgical side (>1) 6: Patients with contraindications of local anesthesia drug allergy and postoperative analgesics (such as NSAID and paracetamol) 7: Pregnant patients 8: Patients with diabetes and vascular diseases; 9: long-term use of opioids antipsychotics antidepressants 10: Injection site infection acute porphyria or kidney disease requiring dialysis 11: Patients with contraindications to regional anesthesia general anesthesia and nerve block insufficiency to assist general anesthesia or change general anesthesia 12: Patients with chronic pain syndrome 13: Patients who are unable to understand the perioperative questionnaire (language problems or cognitive impairments) 14: Have participated in similar studies in the past three months

Design outcomes

Primary

MeasureTime frame
NRS scores at 1 2 and 3 days after surgery (resting pain average daily pain most severe pain and night pain scores);

Secondary

MeasureTime frame
Duration of analgesia and motor block;Anxiety scores at 1 2 and 3 days after surgery;Expression levels of differential genes in peripheral blood before and after surgery;dosage of postoperative analgesics (opioids NSaids);postoperative side effects(headache dizziness nausea vomiting);Quality of sleep day 12 and 3;Daily resting pain average pain most severe pain and nighttime pain scores at days 7 and 30;

Countries

China

Contacts

Public ContactGong Xingrui

Xiangyang Central Hospital

gongxrhbxy@sohu.com15071551981

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026